Awani International
  • LIVE
  • Videos
  • US-China
  • BRICS-RT
  • ASEAN
  • West Asia
  • Shows
  • Podcast
  • BM
    EN
  • LIVE
  • Login
  • BM
    EN
  • LIVE
  • Login
Awani International
  • LIVE
  • Videos
  • US-China
  • BRICS-RT
  • ASEAN
  • West Asia
  • Shows
  • Podcast
Onus now on Russia to show it wants peace in Ukraine, says EU's von der Leyen
Trump suggests Cuba should strike a deal with US
Iran vows to strike back if US attacks
  • PRIVACY POLICY
  • TERMS OF USE
  • ADVERTISE WITH US
  • INVESTOR

Astro AWANI | Copyright © 2025 Measat Broadcast Network Systems Sdn Bhd 199201008561 (240064-A)

US reports nearly 24,000 monkeypox cases

Bernama
Bernama
20/09/2022
10:53 MYT
US reports nearly 24,000 monkeypox cases
Nearly 24,000 monkeypox cases had been confirmed in the United States as of Monday. - REUTERS
LOS ANGELES: Nearly 24,000 monkeypox cases had been confirmed in the United States as of Monday, according to the latest data of the US Centres for Disease Control and Prevention (CDC).
California had the most confirmed cases among US states so far, with 4,656 cases, followed by New York with 3,755 and Florida with 2,398, according to CDC data, reported Xinhua.
Monkeypox infections are rarely fatal, with most cases resolving within two to four weeks. According to the World Health Organisation, the disease has a fatality rate of around 3 per cent to 6 per cent.
However, immunocompromised individuals are more likely to experience severe illness when infected, according to the CDC.
US health officials are warning doctors against overusing the lone drug available to treat monkeypox.
Viruses are constantly evolving to better infect humans and overcome new drugs and vaccines, according to the CDC.
The US Food and Drug Administration has warned that the antiviral drug, called Tecovirimat, is highly vulnerable to resistance. Even a small mutation in the virus could leave the drug ineffective.
-- BERNAMA
Related Topics
#monkeypox
#United States
#Tecovirimat
#California
#English News
Must-Watch Video
Stay updated with our news